rheum Conference-Coverage

Conference Coverage

Treat-to-Target Tapering of TNFi Studied for Noninferiority in PsA, axSpA

01/03/2024

Priyam Vora, Associate Editor

Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.

Patients with psoriatic...

01/03/2024

Rheumatology & Arthritis

Conference Coverage

Positive or Negative? Multimorbidity and Disease Activity in RA

12/27/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...

Investigators examined the association between multimorbidity in rheumatoid arthritis and its association with flares and remission in comparison to seropositivity.

Investigators examined the...

12/27/2023

Rheumatology & Arthritis

Conference Coverage

Black Box Warning No Deterrent to JAKi Adherence in RA

12/27/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...

A retrospective cohort study found that patients with rheumatoid arthritis treated with Janus kinase inhibitors were no less adherent to their medication regimen after the addition of a black box warning by the US Food and Drug Administration

A retrospective cohort study...

12/27/2023

Rheumatology & Arthritis

Conference Coverage

Victoria Konzett, MD, on RA Flares Based on SDAI and CDAI

12/27/2023

Priyam Vora, Associate Editor

During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.

During her presentation on...

12/27/2023

Rheumatology & Arthritis

Conference Coverage

Dr Peter Taylor on Effectiveness of Upadacitinib in RA Pain Management

12/26/2023

Priyam Vora, Associate Editor

Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.

Patients with rheumatoid...

12/26/2023

Rheumatology & Arthritis

Conference Coverage

Gregory McDermott, MD: Predictors of RA-ILD and Subtypes

12/26/2023

Priyam Vora, Associate Editor

Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.

Several factors have been shown...

12/26/2023

Rheumatology & Arthritis

Conference Coverage

Breakthrough COVID-19 Infection Among RA Patients After Third Dose

12/26/2023

Priyam Vora, Associate Editor

In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.

In August 2021, the CDC...

12/26/2023

Rheumatology & Arthritis

Conference Coverage

This or That? Rieke Alten, MD, Reviews Treatment Preferences for RA Patients

12/20/2023

Priyam Vora, Associate Editor

Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.

Findings of an online survey...

12/20/2023

Rheumatology & Arthritis

Conference Coverage

Rheumatoid Arthritis and Long COVID—A Double Whammy

12/20/2023

Priyam Vora, Associate Editor

The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.

The increased odds of Long COVID...

12/20/2023

Rheumatology & Arthritis

Conference Coverage

Is There a Window of Opportunity in Psoriatic Arthritis?

12/13/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...

Early referral to rheumatologists of patients who present with symptoms of psoriatic arthritis (PsA) is associated with better clinical outcomes.

Early referral to...

12/13/2023

Rheumatology & Arthritis

Conference Coverage

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products